+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Legal Cannabis Market Size, Share & Trends Analysis Report by Source (Marijuana, Hemp), by Derivative (CBD, THC), by End Use (Medical Use, Recreational Use, Industrial Use), by Region, and Segment Forecasts, 2022-2030

  • ID: 5390516
  • Report
  • April 2022
  • Region: Global
  • 150 Pages
  • Grand View Research

FEATURED COMPANIES

  • Aurora Cannabis, Inc.
  • Cara Therapeutics Inc.
  • Cronos Group
  • Funding
  • Gw Pharmaceuticals, plc
  • Insys Therapeutics, Inc.
The global legal cannabis market size is expected to reach USD 134.4 billion by 2030. It is expected to expand at a CAGR of 25.3% from 2022 to 2030. The increased legalization across different nations of the usage of cannabis-derived products has gained a lot of popularity. Medical cannabis-based has been used in the treatment of various indications like epileptic seizures, nausea related to chemotherapy, anxiety, and other brain-related diseases. Several studies are being conducted for CBD products in various indications. The medical fraternity has slowly increased acceptance of medical cannabis as well as marijuana and its derivatives owing to its legalization by the governments. Some countries like Canada, the U.S., and Uruguay have legalized its recreational use along with medicinal use. Adult use and recreational use of marijuana is readily available in some of the countries’ markets, thereby increasing adoption and market growth. The COVID-19 pandemic has impeded the growth of the market. Supply chain disruptions and a surge in panic buying scenarios led to the increase in the demand-supply gap, thereby affecting the market growth. However, it is expected to grow post-pandemic with the increased support from governments and ever-increasing demand.



Based on source, the marijuana segment accounted for the largest revenue share of over 70.0% in 2021 and is expected to exhibit the fastest growth rate during the forecast period. Marijuana is easily available and consumers are becoming more aware of its therapeutic properties alongside the more traditional recreational uses. It has been seen to reduce stress and relieve pain, thereby improving sleep irregularities. The decriminalization and legalization of marijuana usage have resulted in a marked reduction in illegal activities surrounding marijuana. CBD is quite potent when it comes to derivatives of the cannabis plant, thus it has emerged as the largest derivative segment with a revenue share of over 65.0% in 2021. The adoption of CBD-based products is increasing rapidly owing to the non-psychoactive nature of the derivative, thereby fueling market growth. In addition, positive attitudes of the medical fraternity toward CBD-based medicines are further propelling the segment growth. In addition, the others
segment is anticipated to grow at the fastest rate during the forecast period owing to rising awareness and acceptance regarding the derivatives, along with increasing geographies sanctioning the use of various cannabinoids for medical and other purposes.

North America dominated the market with a revenue share of over 65.0% in 2021 owing to increasing acceptance of cannabis for medical purposes across the region and changing consumer perception toward cannabis. In addition, the presence of prominent cannabis companies in the North American region is boosting the market growth. Moreover, the Asia region is anticipated to grow at the fastest rate owing to the increasing number of countries sanctioning the use of cannabis, mainly for medical purposes.

Legal Cannabis Market Report Highlights

  • The market growth can be attributed to the increasing legalization of cannabis across the globe.
  • The marijuana source segment dominated the market in 2021 owing to the increasing adoption of marijuana for medical as well as adult use.
  • The CBD derivative segment dominated the market in 2021 owing to the increasing number of countries sanctioning the use of CBD for medical as well as other purposes.
  • by end use, the medical use segment dominated the market in 2021 owing to the rising geriatric population and increasing demand for cannabis for various medical purposes such as the management of chronic pain, mental disorders, chemotherapy-induced nausea and vomiting, and neurological disorders.
  • North America dominated the market in 2021 owing to the growing demand and positive attitude toward cannabis in this region.
Frequently Asked Questions about the Global Legal Cannabis Market

What is the estimated value of the Global Legal Cannabis Market?

The Global Legal Cannabis Market was estimated to be valued at $22.1 Billion in 2022.

What is the growth rate of the Global Legal Cannabis Market?

The growth rate of the Global Legal Cannabis Market is 25.3%, with an estimated value of $134.4 Billion by 2030.

What is the forecasted size of the Global Legal Cannabis Market?

The Global Legal Cannabis Market is estimated to be worth $134.4 Billion by 2030.

Who are the key companies in the Global Legal Cannabis Market?

Key companies in the Global Legal Cannabis Market include Funding, Gw Pharmaceuticals, plc, Aurora Cannabis, Inc., Aphria, Inc. (Prior to Merger With Tilray), Cronos Group, Tilray, Sundial Growers, Inc., Insys Therapeutics, Inc. and Vivo Cannabis Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Aurora Cannabis, Inc.
  • Cara Therapeutics Inc.
  • Cronos Group
  • Funding
  • Gw Pharmaceuticals, plc
  • Insys Therapeutics, Inc.

Chapter 1 Methodology and Scope
1.1 Research Process
1.2 Information Procurement
1.2.1 Purchased database:
1.2.1.1 internal database
1.2.2 Market Formulation & Validation
1.3 Research Methodology
1.4 Research Scope and Assumptions
1.5 Research Methodology
1.5.1 Region Market: Cagr Calculation
1.5.2 Region Based Segment Share Calculation
1.6 List to Data Sources
Chapter 2 Executive Summary
2.1 Market Outlook
2.2 Segment Outlook
2.3 Competitive Insights
2.4 Global Legal Cannabis Market Snapshot
Chapter 3 Global Legal Cannabis Market Variables, Trends & Scope
3.1 Market Segmentation
3.2 Penetration and Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.2 Market Restraint Analysis
3.4 Global Legal Cannabis Industry: History Of Medical Use Of Cannabis
3.5 Global Legal Cannabis Industry: History Of Industrial Use Of Cannabis
3.6 Global Legal Cannabis Industry: Number Of Clinical Trials, by Region
3.7 Global Legal Cannabis Industry: Legalization Timeline
3.7.1 Legalization Landscape (Timeline)
3.7.2 U.S. Legalization Landscape
3.7.3 Global Legal Cannabis Regulatory Scenario, by Country
3.7.3.1 U.S.
3.7.3.1.1 Overview
3.7.3.1.2 Cultivation/Production
3.7.3.1.3 Regulatory Bodies Involved
3.7.3.2 Canada
3.7.3.2.1 Overview
3.7.3.2.2 Cultivation/Production
3.7.3.2.3 Regulatory Bodies Involved
3.7.3.3 Germany
3.7.3.3.1 Overview
3.7.3.3.2 Cultivation/Production
3.7.3.3.3 Regulatory Bodies Involved
3.7.3.4 Italy
3.7.3.4.1 Overview
3.7.3.4.2 Cultivation/Production
3.7.3.4.3 Regulatory Bodies Involved
3.7.3.5 Croatia
3.7.3.5.1 Overview
3.7.3.5.2 Cultivation/Production
3.7.3.5.3 Regulatory Bodies Involved
3.7.3.6 The Netherlands
3.7.3.6.1 Overview
3.7.3.6.2 Cultivation/Production
3.7.3.6.3 Regulatory Bodies Involved
3.7.3.7 Czech Republic
3.7.3.7.1 Overview
3.7.3.7.2 Cultivation/Production
3.7.3.7.3 Regulatory Bodies Involved
3.7.3.8 Poland
3.7.3.8.1 Overview
3.7.3.8.2 Cultivation/Production
3.7.3.8.3 Regulatory Bodies Involved
3.7.3.9 Switzerland
3.7.3.9.1 Overview
3.7.3.9.2 Cultivation/Production
3.7.3.9.3 Regulatory Bodies Involved
3.7.3.10 Australia
3.7.3.10.1 Overview
3.7.3.10.2 Cultivation/Production
3.7.3.10.3 Regulatory Bodies Involved
3.7.3.11 Ururguay
3.7.3.11.1 Overview
3.7.3.11.2 Cultivation/Production
3.7.3.11.3 Regulatory Bodies Involved
3.7.3.12 Colombia
3.7.3.12.1 Overview
3.7.3.12.2 Cultivation/Production
3.7.3.12.3 Regulatory Bodies Involved
3.7.3.13 Argentina
3.7.3.13.1 Overview
3.7.3.13.2 Cultivation/Production
3.7.3.13.3 Regulatory Bodies Involved
3.7.3.14 Chile
3.7.3.14.1 Overview
3.7.3.14.2 Cultivation/Production
3.7.3.14.3 Regulatory Bodies Involved
3.7.3.15 Mexico
3.7.3.15.1 Overview
3.7.3.15.2 Cultivation/Production
3.7.3.15.3 Regulatory Bodies Involved
3.7.3.16 Israel
3.7.3.16.1 Overview
3.7.3.16.2 Cultivation/Production
3.7.3.16.3 Regulatory Bodies Involved
3.8 Global Legal Cannabis Industry: Consumption Pattern Analysis, by Region
3.8.1 Consumption Pattern Analysis, by Region
3.8.1.1 North America
3.8.1.2 Europe
3.8.1.3 Asia Pacific
3.8.1.4 Latin America
3.8.1.5 Mea
3.8.2 Estimated Number Of Cannabis Users From 2016 To 2026, by Country
3.8.3 Estimated Number Of Medical Marijuana Users From 2016 To 2026, by Country
3.9 Global Legal Cannabis Industry: Potential Trade Opportunity
3.9.1 Trade Opportunity Analysis, by Region
3.9.1.1 North America
3.9.1.2 Europe
3.9.1.3 Asia Pacific
3.9.1.4 Latin America
3.9.1.5 Mea
3.9.2 Global Legal Cannabis Trade Route
3.9.3 Global Hemp Trade Route
3.9.4 Countries Importing and Exporting Medical Cannabis (Flower)
3.9.5 Countries Importing and Exporting Hemp Seeds
3.9.6 Countries Importing and Exporting Hemp Seed Oil
3.10 Global Legal Cannabis Industry: Seed To Shelf Story
3.10.1 Section Description
3.10.1.1 Cultivators and Growers
3.10.1.2 Manufacturers and Producers
3.10.1.3 Testers
3.10.1.4 Wholesalers and Distributors
3.10.1.5 Retailers
3.10.2 Supply Chain Analysis
3.10.2.1 Profit Margin Estimation
3.11 Global Legal Cannabis Industry: Country Case Studies
3.11.1 U.S.
3.11.1.1 Legalization Of Cannabis:
3.11.1.2 Reason For Legalization:
3.11.1.3 Scenario After Legalization and Consumer Attitudes:
3.11.1.4 Competitive Landscape Post Legalization:
3.11.2 Canada
3.11.2.1 Legalization Of Cannabis:
3.11.2.2 Reason For Legalization:
3.11.2.3 Scenario After Legalization:
3.11.2.4 Consumer Attitudes Toward Legalization:
3.11.2.5 Competitive Landscape Post Legalization:
3.11.3 Thailand
3.11.3.1 Legalization Of Cannabis:
3.11.3.2 Licensing and Import/Export Scenario As Per Legalization Regulations:
3.11.3.3 Reason For Legalization:
3.11.3.4 Scenario After Legalization:
3.11.3.5 Competitive Landscape Post Legalization:
3.11.4 South Africa
3.11.4.1 Legalization Of Cannabis:
3.11.4.2 Reasons For Legalization:
3.11.4.3 Scenario After Legalization:
3.11.4.4 Competitive Landscape Post Legalization:
3.11.5 Uruguay
3.11.5.1 Legalization Of Cannabis:
3.11.5.2 Reason For Legalization:
3.11.5.3 Scenario After Legalization:
3.11.5.4 Consumer Attitudes Toward Legalization:
3.115.5 Competitive Landscape Post Legalization:
Chapter 4 Global Legal Cannabis Market: Source Estimates & Trend Analysis
4.1 Segment Dashboard
4.2 Global Legal Cannabis Market: Source Movement Analysis, (USD Million) 2021 & 2030
4.2.1 Marijuana
4.2.1.1 Marijuana Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.2.1.2 Flowers
4.2.1.2.1 Flowers Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.2.1.3 Oil and Tinctures
4.2.1.3.1 Oil and Tinctures Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.2.2 Hemp
4.2.2.1 Hemp Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.2.2.2 Hemp Cbd
4.2.2.2.1 Hemp Cbd Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.2.2.3 Supplements
4.2.2.3.1 Supplements Market Estimates and Forecasts, 2016 - 2030 (USD Million)
4.2.2.4 Industrial Hemp
4.2.2.4.1 Industrial Hemp Market Estimates and Forecasts, 2016 - 2030 (USD Million)
Chapter 5 Global Legal Cannabis Market: Derivative Estimates & Trend Analysis
5.1 Segment Dashboard
5.2 Global Legal Cannabis Market: Derivative Movement Analysis, USD Million, 2021 & 2030
5.2.1 Cbd
5.2.1.1 Cbd Market Estimates and Forecasts, 2016 - 2030 (USD Million)
5.2.2 Thc
5.2.2.1 Thc Market Estimates and Forecasts, 2016 - 2030 (USD Million)
5.2.3 Others
5.2.3.1 Others Market Estimates and Forecasts, 2016 - 2030 (USD Million)
Chapter 6 Global Legal Cannabis Market: End-Use Estimates & Trend Analysis
6.1 Segment Dashboard
6.2 Global Legal Cannabis Market: End-Use Movement Analysis, USD Million, 2021 & 2030
6.2.1 Medical Use
6.2.1.1 Medical Use Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.2 Cancer
6.2.1.2.1 Cancer Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.3 Chronic Pain
6.2.1.3.1 Chronic Pain Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.4 Depression and Anxiety
6.2.1.4.1 Depression and Anxiety Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.5 Arthritis
6.2.1.5.1 Arthritis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.6 Diabetes
6.2.1.6.1 Diabetes Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.7 Glaucoma
6.2.1.7.1 Glaucoma Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.8 Migraines
6.2.1.8.1 Migraines Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.9 Epilepsy
6.2.1.9.1 Epilepsy Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.10 Multiple Sclerosis
6.2.1.10.1 Multiple Sclerosis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.11 Aids
6.2.1.11.1 Aids Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.12 Amyotrophic Lateral Sclerosis
6.2.1.12.1 Amyotrophic Lateral Sclerosis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.13 Alzheimer's
6.2.1.13.1 Alzheimer's Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.14 Post Traumatic Stress Disorder (Ptsd)
6.2.1.14.1 Post Traumatic Stress Disorder (Ptsd) Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.15 Parkinson's
6.2.1.15.1 Parkinson's Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.16 Tourette’s
6.2.1.16.1 Tourette’s Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.1.17 Others
6.2.1.17.1 Others Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.2 Recreational Use
6.2.2.1 Recreational Use Market Estimates and Forecasts, 2016 - 2030 (USD Million)
6.2.3 Industrial Use
6.2.3.1 Industrial Use Market Estimates and Forecasts, 2016 - 2030 (USD Million)
Chapter 7 Global Legal Cannabis Market: Competitive Analysis
7.1 Company Market Position Analysis
7.2 Strategic Framework
Chapter 8 Global Legal Cannabis Market: Regional Estimates & Trend Analysis: by Source, Derivative, and End Use
8.1 Regional Market Snapshot
8.2 Global Legal Cannabis Market: Regional Movement Analysis, USD Million, 2021 & 2030, USD Million
8.3 North America
8.3.1 North America Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.3.2 U.S.
8.3.2.1 U.S. Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.3.3 Canada
8.3.3.1 Canada Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.4 Europe
8.4.1 Europe Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.4.2 Germany
8.4.2.1 Germany Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.4.3 Uk
8.4.3.1 Uk Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.4.4 Italy
8.4.4.1 Italy Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.4.5 Poland
8.4.5.1 Poland Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.4.6 Czech Republic
8.4.6.1 Czech Republic Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.4.7 Switzerland
8.4.7.1 Switzerland Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.4.8 Croatia
8.4.8.1 Croatia Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.4.9 Netherlands
8.4.9.1 Netherlands Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.4.10 Spain
8.4.10.1 Spain Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.5 Asia
8.5.1 Asia Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.5.2 China
8.5.2.1 China Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.5.3 India
8.5.3.1 India Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.5.4 Japan
8.5.4.1 Japan Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.5.5 Thailand
8.5.5.1 Thailand Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.6 Oceania
8.6.1 Oceania Legal Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.6.2 Australia
8.6.2.1 Australia Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.6.3 New Zeland
8.6.3.1 New Zeland Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.7 Latin America and The Caribbean
8.7.1 Latin America and Caribbean Legal Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.7.2 Brazil
8.7.2.1 Brazil Legal Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.7.3 Mexico
8.7.3.1 Mexico Legal Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.7.4 Uruguay
8.7.4.1 Uruguay Legal Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.7.4 Colombia
8.7.4.1 Colombia Legal Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
8.8 Africa
8.8.1 Africa Legal Cannabis Market Estimates and Forecasts, 2016 - 2030 (USD Million)
Chapter 9 Competitive Landscape
9.1 Company Profiles
9.1.1 CANOPY GROWTH CORPORATION
9.1.1.1 Funding
9.1.1.2 Number of Employees
9.1.1.3 Headquarters
9.1.1.4 Business Model (Product Offerings)
9.1.1.5 Growers, Manufacturers, Retailers
9.1.1.6 Revenue 2020(USD Mn)
9.1.1.7 Net Loss 2020 (USD Mn
9.1.1.8 Valuation (USD Mn)
9.1.1.9 Regions With Commercial Presence
9.1.2 GW PHARMACEUTICALS, PLC
9.1.2.1 Funding
9.1.2.2 Number of Employees
9.1.2.3 Headquarters
9.1.2.4 Business Model (Product Offerings)
9.1.2.5 Growers, Manufacturers, Retailers
9.1.2.6 Revenue 2020(USD Mn)
9.1.2.7 Net Loss 2020 (USD Mn
9.1.2.8 Valuation (USD Mn)
9.1.2.9 Regions With Commercial Presence
9.1.3 AURORA CANNABIS, INC.
9.1.3.1 Funding
9.1.3.2 Number of Employees
9.1.3.3 Headquarters
9.1.3.4 Business Model (Product Offerings)
9.1.3.5 Growers, Manufacturers, Retailers
9.1.3.6 Revenue 2020(USD Mn)
9.1.3.7 Net Loss 2020 (USD Mn
9.1.3.8 Valuation (USD Mn)
9.1.3.9 Regions With Commercial Presence
9.1.4 APHRIA, INC. (PRIOR TO MERGER WITH TILRAY)
9.1.4.1 Funding
9.1.4.2 Headquarters
9.1.4.3 Business Model (Product Offerings)
9.1.4.4 Growers, Manufacturers, Retailers
9.1.4.5 Valuation (USD Mn)
9.1.4.6 Regions With Commercial Presence
9.1.5 CRONOS GROUP
9.1.5.1 Funding
9.1.5.2 Number of Employees
9.1.5.3 Headquarters
9.1.5.4 Business Model (Product Offerings)
9.1.5.5 Growers, Manufacturers, Retailers
9.1.5.6 Revenue 2020(USD Mn)
9.1.5.7 Net Loss 2020 (USD Mn
9.1.5.8 Valuation (USD Mn)
9.1.5.9 Regions With Commercial Presence
9.1.6 TILRAY
9.1.6.1 Funding
9.1.6.2 Number of Employees
9.1.6.3 Headquarters
9.1.6.4 Business Model (Product Offerings)
9.1.6.5 Growers, Manufacturers, Retailers
9.1.6.6 Revenue 2020(USD Mn)
9.1.6.7 Net Loss 2020 (USD Mn
9.1.6.8 Valuation (USD Mn)
9.1.6.9 Regions With Commercial Presence
9.1.7 SUNDIAL GROWERS, INC.
9.1.7.1 Funding
9.1.7.2 Number of Employees
9.1.7.3 Headquarters
9.1.7.4 Business Model (Product Offerings)
9.1.7.5 Growers, Manufacturers, Retailers
9.1.7.6 Revenue 2020(USD Mn)
9.1.7.7 Net Loss 2020 (USD Mn
9.1.7.8 Regions With Commercial Presence
9.1.8 INSYS THERAPEUTICS, INC.
9.1.8.1 Funding
9.1.8.2 Number of Employees
9.1.8.3 Headquarters
9.1.8.4 Business Model (Product Offerings)
9.1.8.5 Growers, Manufacturers, Retailers
9.1.8.6 Revenue 2020(USD Mn)
9.1.8.7 Net Loss 2020 (USD Mn
9.1.8.8 Regions With Commercial Presence
9.1.9 THE SCOTTS COMPANY LLC
9.1.9.1 Number of Employees
9.1.9.2 Headquarters
9.1.9.3 Business Model (Product Offerings)
9.1.9.4 Growers, Manufacturers, Retailers
9.1.9.5 Revenue 2020(USD Mn)
9.1.9.6 Net Loss 2020 (USD Mn
9.1.9.7 Valuation (USD Mn)
9.1.9.8 Regions With Commercial Presence
9.1.10 VIVO CANNABIS INC.,
9.1.10.1 Headquarters
9.1.10.2 Business Model (Product Offerings)
9.1.10.3 Growers, Manufacturers, Retailers
9.1.10.4 Revenue 2020(USD Mn)
9.1.10.5 Net Loss 2020 (USD Mn
9.1.10.6 Valuation (USD Mn)
9.1.10.7 Regions With Commercial Presence
9.1.11 CARA THERAPEUTICS INC.
9.1.11.1 Funding
9.1.11.2 Number of Employees
9.1.11.3 Headquarters
9.1.11.4 Business Model (Product Offerings)
9.1.11.5 Growers, Manufacturers, Retailers
9.1.11.6 Revenue 2020(USD Mn)
9.1.11.7 Net Loss 2020 (USD Mn
9.1.11.8 Valuation (USD Mn)
9.1.11.9 Regions With Commercial Presence
Note: Product cover images may vary from those shown
  • Funding
  • Gw Pharmaceuticals, plc
  • Aurora Cannabis, Inc.
  • Aphria, Inc. (Prior to Merger With Tilray)
  • Cronos Group
  • Tilray
  • Sundial Growers, Inc.
  • Insys Therapeutics, Inc.
  • the Scotts Company LLC
  • Vivo Cannabis Inc.
  • Cara Therapeutics Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...